Author： Breunig Ian M Shaya Fadia T Scharf Steven M
Publisher： Informa Healthcare
ISSN： 1473-7167
Source： Expert Review of Pharmacoeconomics and Outcomes Research, Vol.12, Iss.6, 2012-12, pp. : 725-731
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Group care intervention `feasible and cost-effective' in diabetes
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 389, 2002-01 ,pp. :
Access to resources
Recommend
ASCO report highlights challenges in delivering high-quality care
Cancer, Vol. 121, Iss. 14, 2015-07 ,pp. :
Losartan a "cost-effective intervention" for hypertension
Inpharma, Vol. 1, Iss. 1518, 2005-01 ,pp. :
Dutasteride "cost-effective" for BPH in Poland
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 517, 2006-01 ,pp. :
Searching for cost-effective options in Italy
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 667, 2012-01 ,pp. :